Therapeutic Trials in HIV/HCV Coinfection: ION-4, Ally-2, and Viroteam 2015
In the study of therapeutic trials in HIV/HCV coinfection between 2014-2015, notable trials included ION-4 with LDV/SOF treatment for 12 weeks in HCV/HIV co-infection patients, showing high SVR rates in both treatment-naive and experienced patients. Another trial, Ally-2, involved Daclatasvir and So
0 views • 15 slides
Understanding Helminths and Immunomodulation: A Comprehensive Study
Helminths, parasitic organisms affecting a large part of the global population, can modify the immune response through immunomodulation. This research delves into the interaction between helminths, microbiome, and immune response, exploring the effects on macrophages, alternative activation, and the
0 views • 28 slides
Challenges in the Management and Treatment of HIV/Hepatitis C Virus Coinfection
This presentation by Dr. Ricardo A. Franco focuses on the challenges faced in managing and treating patients with HIV/Hepatitis C virus coinfection. It discusses the burden of HCV mono-infection and HIV/HCV co-infection, the impact of HIV co-infection on survival in HCV-related cirrhosis, and the ro
0 views • 26 slides